secwatch.observer — SEC 8-K summary
======================================

Issuer:     CRESCENT BIOPHARMA, INC. (CBIO)
CIK:        0001253689
Form:       8-K
Filed at:   2022-06-03T23:59:59+00:00
Accession:  0001558370-22-009711
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

GlycoMimetics receives Nasdaq minimum bid price deficiency notice
-----------------------------------------------------------------

- Bid price below $1.00 for 30 consecutive business days; 180-day cure period until Nov 28, 2022.
- Compliance requires closing bid price at or above $1.00 for at least 10 consecutive business days.
- If not cured, Company may transfer to Nasdaq Capital Market for additional 180-day period if eligible.
- Noncompliance has no immediate effect on listing or trading of common stock on The Nasdaq Global Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1253689/000155837022009711/0001558370-22-009711-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1253689/000155837022009711/glyc-20220531x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-009711

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer